Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by 2quick154on Jul 29, 2017 7:52pm
187 Views
Post# 26525766

RE:RE:RE:one news release away from 3.00 +

RE:RE:RE:one news release away from 3.00 + Or perhaps I am being realistic ?  I have been long for 3 years now - and I am tired of blatant pumpers like yourself.

Get your head out of the sand - the company has not delivered in terms of Share Price Appreciation which is why I'm here.  I am straight up here to make money and that has not materialized over the last 3 years.

We need to hold management accountable, and question whether they are capable to take us to the next level.  Now is not the time to pump, show me the money and we can talk.

Why am I invested?  Because I can see the long term potential in the next 3-5 years with the wide range of plasminogen applications, the potential of 4050, and the ability long term to produce multiple proteins from blood as approvals happen over time.

However, as it stands... at this moment we are not one news release away from $3.00 IMHO.

1) Approval for plasminogen deficiency will obviously help the SP and de-risk the model, but can we honesty expect more than $20 M in PG sales for 2018?  I just don't see the massive SP appreciation for such an application.

2) A voucher would help the SP, but how much?  Maybe $.50 - .60 tops? It is worth about $125 M, but ours will not be the only one on the market and how long could it take to sell?

3) Although I can see smaller deals happening at this point, I do not see any MAJOR 4050 deals happening until after Phase II Placebo studies are complete.  I imagine Pierre's asking price is high and can not see it happening at this time.

So although we should get there eventually, how long will it take and will Pierre be able to complete a deal with someone REPUTABLE ??

We can talk positive, we can talk negative, but lets try and keep it realistic.


Bullboard Posts